These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35056346)

  • 1. Colonic Diverticulosis and Non-Alcoholic Fatty Liver Disease: Is There a Connection?
    Pantic I; Lugonja S; Rajovic N; Dumic I; Milovanovic T
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056346
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical outcomes of non-alcoholic fatty liver disease: Polish-case control study.
    Kempiński R; Łukawska A; Krzyżanowski F; Ślósarz D; Poniewierka E
    Adv Clin Exp Med; 2019 Dec; 28(12):1615-1620. PubMed ID: 31025557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity, metabolic syndrome and the risk of development of colonic diverticulosis.
    Kopylov U; Ben-Horin S; Lahat A; Segev S; Avidan B; Carter D
    Digestion; 2012; 86(3):201-5. PubMed ID: 22907510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
    Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
    J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonic diverticulosis and the metabolic syndrome: an association?
    Teixeira C; Trabulo D; Ribeiro S; Martins CR; Alves AL; Cremers I; Oliveira AP
    Rev Esp Enferm Dig; 2017 Nov; 109(11):768-771. PubMed ID: 28776378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease.
    Semmler G; Balcar L; Wernly S; Völkerer A; Semmler L; Hauptmann L; Wernly B; Aigner E; Niederseer D; Datz C
    Front Endocrinol (Lausanne); 2023; 14():1244405. PubMed ID: 37842290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
    van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
    Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To Assess Non Alcoholic Fatty Liver Disease in Patients with Clinical and Subclinical Hypothyroidism.
    R M; R M; S R; Ganga R
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
    van den Berg EH; Amini M; Schreuder TC; Dullaart RP; Faber KN; Alizadeh BZ; Blokzijl H
    PLoS One; 2017; 12(2):e0171502. PubMed ID: 28152105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIV.
    Lake JE; Taron J; Ribaudo HJ; Leon-Cruz J; Utay NS; Swaminathan S; Fitch KV; Kileel EM; Paradis K; Fulda ES; Ho KS; Luetkemeyer AF; Johnston CD; Zanni MV; Douglas PS; Grinspoon SK; Lu MT; Fichtenbaum CJ;
    AIDS; 2023 Nov; 37(14):2149-2159. PubMed ID: 37503623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study.
    Pereira ENGDS; Paula DP; de Araujo BP; da Fonseca MJM; Diniz MFHS; Daliry A; Griep RH
    World J Gastroenterol; 2021 Aug; 27(29):4913-4928. PubMed ID: 34447235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interrelationship Among Non-Alcoholic Fatty Liver Disease, Colonic Diverticulosis and Metabolic Syndrome.
    Milovanovic T; Pantic I; Dragasevic S; Lugonja S; Dumic I; Rajilic-Stojanovic M
    J Gastrointestin Liver Dis; 2021 Jun; 30(2):274-282. PubMed ID: 33951119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.
    Chen K; Sng WK; Quah JH; Liu J; Chong BY; Lee HK; Wang XF; Tan NC; Chang PE; Tan HC; Bee YM; Goh GBB
    PLoS One; 2020; 15(8):e0236977. PubMed ID: 32822391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria.
    Boyraz M; Hatipoğlu N; Sarı E; Akçay A; Taşkın N; Ulucan K; Akçay T
    Obes Res Clin Pract; 2014; 8(4):e356-63. PubMed ID: 25091357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
    Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
    Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset.
    Martinez-Urbistondo D; Huerta A; Navarro-González D; Sánchez-Iñigo L; Fernandez-Montero A; Landecho MF; Martinez JA; Pastrana-Delgado JC
    Eur J Clin Invest; 2023 Oct; 53(10):e14036. PubMed ID: 37303077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?
    Russo GI; Cimino S; Castelli T; Favilla V; Gacci M; Carini M; Condorelli RA; La Vignera S; Calogero AE; Motta F; Puzzo L; Caltabiano R; Morgia G
    Prostate; 2016 Dec; 76(16):1528-1535. PubMed ID: 27458062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and risk factors for histopathologic characteristics of non-alcoholic fatty liver disease in South America.
    Akambase JA; Prieto JE; Mattos AZ; Mattos AA; Carrera E; Díaz-Ferrer J; Gallardo P; Curia A; Ballerga EG; Tovo CV; Balderramo D; Debes JD
    Aliment Pharmacol Ther; 2023 Sep; 58(5):526-536. PubMed ID: 37349900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis.
    Bi Y; Wang JL; Li ML; Zhou J; Sun XL
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3142. PubMed ID: 30767421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.